T-cell large granular lymphocyte leukemia medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

T-cell large granular lymphocyte leukemia Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating T-cell large granular lymphocyte leukemia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
T-cell large granular lymphocyte leukemia medical therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of T-cell large granular lymphocyte leukemia medical therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on T-cell large granular lymphocyte leukemia medical therapy
CDC on T-cell large granular lymphocyte leukemia medical therapy
T-cell large granular lymphocyte leukemia medical therapy in the news
Blogs on T-cell large granular lymphocyte leukemia medical therapy
Directions to Hospitals Treating Type page name here
Risk calculators and risk factors for T-cell large granular lymphocyte leukemia medical therapy

Medical Therapy

Pharmacotherapy

Alemtuzumab has been investigated for use in treatment of refractory T-cell large granular lymphocytic leukemia.